BAFFR

BAFFR 분자 정보

영어 이름B-cell activating factor receptor시판 약물 수0
임상 약물 수14표적 별명BAFFR,B Cell-Activating Factor Receptor,Prolixin,BROMIX,CD268,Tumor Necrosis Factor Receptor Superfamily, Member 13C,Tumor Necrosis Factor Receptor Superfamily Member 13C,BR3,CVID4,CD268 Antigen,BAFF Receptor,B-Cell Activation Factor Receptor,BAFF-R,TNF Receptor Superfamily Member 13C,BLyS Receptor 3,B-Cell-Activating Factor Receptor,TNFRSF13C
최고 연구 개발 단계NDA/BLA
영어 이름B-cell activating factor receptor
표적 별명BAFFR,B Cell-Activating Factor Receptor,Prolixin,BROMIX,CD268,Tumor Necrosis Factor Receptor Superfamily, Member 13C,Tumor Necrosis Factor Receptor Superfamily Member 13C,BR3,CVID4,CD268 Antigen,BAFF Receptor,B-Cell Activation Factor Receptor,BAFF-R,TNF Receptor Superfamily Member 13C,BLyS Receptor 3,B-Cell-Activating Factor Receptor,TNFRSF13C
시판 약물 수0
임상 약물 수14
최고 연구 개발 단계NDA/BLA

BAFFR분자 배경

BAFF receptor (B-cell activating factor receptor, BAFF-R), also known as tumor necrosis factor receptor superfamily member 13C (TNFRSF13C), is a membrane protein of the TNF receptor superfamily which recognizes BAFF. B-cell activating factor (BAFF) enhances B-cell survival in vitro and is a regulator of the peripheral B-cell population. Overexpression of BAFF in mice results in mature B-cell hyperplasia and symptoms of systemic lupus erythematosus (SLE). Also, some SLE patients have increased levels of BAFF in serum. Therefore, it has been proposed that abnormally high levels of BAFF may contribute to the pathogenesis of autoimmune diseases by enhancing the survival of autoreactive B cells.

BAFFR분자 별명

BAFFR,TNFRSF13C,BROMIX,CD268,CVID4,prolixin,BAFF-R

항체 프로젝트 거래 플랫폼

프로젝트 이름프로젝트 단계분자 유형분자 출처질병 영역적응증
BAFFR&CD3 BsAb - 01PCCBispecificHumanized Mouse,NanobodyHematological Malignancy,AutoImmunityBlood tumor,Autoimmune disease

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Fully Human BAFF-R Chimeric Antigen Receptor T-Cell (Taihe Chunyu)Phase 2 ClinicalHebei Tahoe Chunyu Biotechnology Co LtdLeukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Waldenstrom Macroglobulinemia
상세
Anti-BAFFR CAR T therapy(The General Hospital Of Tianjin Medical University)BAFFR CARTPhase 2 ClinicalThe General Hospital Of Tianjin Medical UniversityMyasthenia Gravis; Myositis; Neuromyelitis Optica; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
상세
ESG-206ESG-206Phase 2 ClinicalShanghai Escugen Biotechnology Co LtdLupus Erythematosus, Systemic; Lymphoma, B-Cell; Neoplasms; Purpura, Thrombocytopenic, Idiopathic; Sjogren's Syndrome
상세
dual anti-CD19/anti-BAFF CAR T-cell therapy (Shanghai YaKe Biotechnology/Zhejiang University)Phase 1 ClinicalShanghai Yake Biotechnology Co LtdAutoimmune Diseases; Dermatomyositis; Lupus Erythematosus, Systemic; Nephritis; Neuromyelitis Optica; Scleroderma, Systemic
상세
SSS-68SSS68; SSS-68Phase 1 ClinicalShenyang Sunshine Pharmaceutical Co LtdGlomerulonephritis, IGA
상세
BAFF-R CAR-T cells therapy (Topcel-KH Pharmaceutical)Phase 1 ClinicalJiangsu Topcel-KH Pharmaceutical Co LtdLymphoma, B-Cell
상세
BAFFR CAR-T cell therapy (Bio-gene Technology)Phase 1 ClinicalGuangzhou Bio-Gene Technology Co LtdPrecursor Cell Lymphoblastic Leukemia-Lymphoma
상세
LY-4152199LY-4152199; LY4152199Phase 1 ClinicalEli Lilly And CompanyLymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin
상세
B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells therapy(Mayo Clinic)MC10029; MC-10029Phase 1 ClinicalMayo ClinicLeukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell
상세
CD19-BAFF Targeted CAR T-cells Therapy(YaKe Biotechnology)Phase 1 ClinicalShanghai YaKe Biotechnology Co Ltd, Zhejiang UniversityAutoimmune Diseases; Lymphoma, B-Cell; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
상세
KD-6005KD-6005; KD6005Phase 1 ClinicalShanghai Celgen Bio-Pharmaceutical Co Ltd, Shanghai Kanda Bio-Technology Co LtdArthritis, Rheumatoid
상세
AritinerceptAUR-200; AUR200Phase 1 ClinicalThunderbolt Pharma IncAutoimmune Diseases
상세
JH-013JH-013Phase 1 ClinicalBiotech Pharmaceuticals Co LtdArthritis, Rheumatoid; Hematologic Neoplasms; Lupus Erythematosus, Systemic; Sjogren's Syndrome
상세
BAFFR-CAR T cell therapy (PeproMene Bio)PMB-101; PMB-CT01Phase 1 ClinicalCity Of Hope National Medical Center, PeproMene Bio IncLeukemia, Biphenotypic, Acute; Lymphoma, B-Cell; Lymphoma, Follicular; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호